Skip to main content
. 2016 May 12;11(5):e0155106. doi: 10.1371/journal.pone.0155106

Table 1. Summary of patients.

Histopathological diagnosis Number of mIDH1 patients Age (years) WHO grade
Median Range
diffuse astrocytoma 6 (23.1%) 41 30–62 II
oligodendroglioma 7 (26.9%) 48.9 31–81 II
oligoastrocytoma 5 (19.2%) 46.8 26–74 II
anaplastic astrocytoma 2 (7.7%) 46 34–58 III
anaplastic oligodendroglioma 1 (3.8%) 38 38 III
anaplastic oligoastrocytoma 2 (7.7%) 41 36–46 III
glioblastoma 3 (11.5 %) 60.3 43–75 IV
Total 26 46.7 26–81